학술논문

Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study
Document Type
Article
Source
In Journal of Geriatric Oncology November 2022 13(8):1172-1177
Subject
Language
ISSN
1879-4068